RNF5 and primary effusion lymphoma: Both RNF5 silencing and RNF5 loss dramatically suppressed xenograft tumor growth (Figs 6A, 6B and 7A), suggesting that inhibition of RNF5 effectively suppressed tumor growth of primary effusion lymphoma.